Oncology
Conference Coverage
Bupivacaine following Mohs surgery reduces opioid use, study finds
Recent research has shown that Mohs micrographic surgeons have the highest rates of opioid prescribing of all dermatologists.
Latest News
Doctor accused of ‘fraudulent concealment’ can’t be held liable
The Iowa Supreme Court dismissed a knotty claim against a local doctor and hospital accused of concealing a woman’s renal cancer.
Feature
Q&A with Hubert (Hugh) Greenway, MD
“Every patient who comes to see me has a story, so I try to understand their story,” Dr. Hugh Greenway said.
Conference Coverage
Which solid organ transplant recipients face the highest risk of skin cancer?
Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.
From the Journals
Which breast cancer surgery leads to better quality of life?
Superior psychosocial and sexual well-being at 10 years after surgery was reported by women who underwent breast-conserving surgery and adjuvant...
From the Journals
Surgery shows no survival, morbidity benefit for mild hyperparathyroidism
A decade-long randomized trial shows nearly identical outcomes in most measures in patients with mild parathyroid tumors who did and did not...
From the Journals
Live-donor liver transplants for patients with CRC liver mets
"For the first time, we have been able to demonstrate [outside of Norway] that liver transplantation for patients with unresectable liver...
Feature
Hands trained for surgery now on machine gun: Kyiv oncologist
In the city of Mariupol, “doctors and patients have been taken hostage,” one surgical oncologist said, used by Russian forces as a human shield....
Latest News
Can immunotherapy replace surgery for stomach cancer?
The complete pathologic response rate to neoadjuvant nivolumab/ipilimumab was 59%.
From the Journals
U.S. cancer deaths continue to fall, especially lung cancer
There has been an overall decline of 32% in cancer deaths as of 2019.
Conference Coverage
In metastatic breast cancer, primary resections on the decline
The trend follows randomized, controlled trials that showed no survival benefit to surgery.